Normobaric oxygen: a novel approach for treating chronic cerebral circulation insufficiency

Jiayue Ding,1–3,* Da Zhou,1–3,* Cheng Liu,1,4 Liqun Pan,1–3 Jingyuan Ya,1–3 Yuchuan Ding,3,5 Xunming Ji,2,3,6 Ran Meng1–3 1Department of Neurology, Xuanwu Hospital, Capital Medical University, Beijing 100053, China; 2Advanced Center of Stroke, Beiji...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Ding J, Zhou D, Liu C, Pan L, Ya J, Ding Y, Ji X, Meng R
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2019
Materias:
Acceso en línea:https://doaj.org/article/820678d9e6cc4b378a4c9d2df73c5342
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:820678d9e6cc4b378a4c9d2df73c5342
record_format dspace
spelling oai:doaj.org-article:820678d9e6cc4b378a4c9d2df73c53422021-12-02T04:29:47ZNormobaric oxygen: a novel approach for treating chronic cerebral circulation insufficiency1178-1998https://doaj.org/article/820678d9e6cc4b378a4c9d2df73c53422019-03-01T00:00:00Zhttps://www.dovepress.com/normobaric-oxygen-a-novel-approach-for-treating-chronic-cerebral-circu-peer-reviewed-article-CIAhttps://doaj.org/toc/1178-1998Jiayue Ding,1–3,* Da Zhou,1–3,* Cheng Liu,1,4 Liqun Pan,1–3 Jingyuan Ya,1–3 Yuchuan Ding,3,5 Xunming Ji,2,3,6 Ran Meng1–3 1Department of Neurology, Xuanwu Hospital, Capital Medical University, Beijing 100053, China; 2Advanced Center of Stroke, Beijing Institute for Brain Disorders, Beijing 100053, China; 3Department of China-America Institute of Neuroscience, Xuanwu Hospital, Capital Medical University, Beijing 100053, China; 4Department of Neurology, Yongxin People’s Hospital, Ji’an 343400, China; 5Department of Neurosurgery, Wayne State University School of Medicine, Detroit, MI 48201, USA; 6Department of Neurosurgery, Xuanwu Hospital, Capital Medical University, Beijing 100053, China *These co-first authors contributed equally to this work Abstract: Chronic cerebral circulation insufficiency (CCCI) is viewed as an alarming state induced by long-term reduction in cerebral perfusion, which is associated with neurological deficits and high risk of stroke occurrence or recurrence. CCCI accounts for a large proportion of both outpatients and inpatients with cerebrovascular diseases, while management of CCCI remains a formidable challenge to clinicians. Normobaric oxygen (NBO) is an adjuvant hyperoxygenation intervention supplied with one atmosphere pressure (1 ATA =101.325 kPa). A plethora of studies have demonstrated the efficacy of NBO on the penumbra in acute stroke. NBO has been shown to increase the oxygen pressure, raise the intracranial blood flow, protect blood–brain barrier and enhance neuroprotective effects. As similar underlying mechanisms are shared by the penumbra in stroke and the ischemic–hypoxic brain tissues in CCCI, we speculate that NBO may serve as a promising therapeutic strategy for attenuating short-term symptoms or improving long-term clinical outcomes among patients with CCCI. Due to the scant research exploring the efficacy and safety of NBO for treating CCCI so far, both experimental and clinical studies are warranted to verify our hypothesis in the future. Keywords: chronic cerebral circulation insufficiency, normobaric oxygen, therapeutic strategy, stroke, clinical outcomeDing JZhou DLiu CPan LYa JDing YJi XMeng RDove Medical Pressarticlechronic cerebral ischemianormobaric oxygentherapeutic strategystrokeclinical outcomeGeriatricsRC952-954.6ENClinical Interventions in Aging, Vol Volume 14, Pp 565-570 (2019)
institution DOAJ
collection DOAJ
language EN
topic chronic cerebral ischemia
normobaric oxygen
therapeutic strategy
stroke
clinical outcome
Geriatrics
RC952-954.6
spellingShingle chronic cerebral ischemia
normobaric oxygen
therapeutic strategy
stroke
clinical outcome
Geriatrics
RC952-954.6
Ding J
Zhou D
Liu C
Pan L
Ya J
Ding Y
Ji X
Meng R
Normobaric oxygen: a novel approach for treating chronic cerebral circulation insufficiency
description Jiayue Ding,1–3,* Da Zhou,1–3,* Cheng Liu,1,4 Liqun Pan,1–3 Jingyuan Ya,1–3 Yuchuan Ding,3,5 Xunming Ji,2,3,6 Ran Meng1–3 1Department of Neurology, Xuanwu Hospital, Capital Medical University, Beijing 100053, China; 2Advanced Center of Stroke, Beijing Institute for Brain Disorders, Beijing 100053, China; 3Department of China-America Institute of Neuroscience, Xuanwu Hospital, Capital Medical University, Beijing 100053, China; 4Department of Neurology, Yongxin People’s Hospital, Ji’an 343400, China; 5Department of Neurosurgery, Wayne State University School of Medicine, Detroit, MI 48201, USA; 6Department of Neurosurgery, Xuanwu Hospital, Capital Medical University, Beijing 100053, China *These co-first authors contributed equally to this work Abstract: Chronic cerebral circulation insufficiency (CCCI) is viewed as an alarming state induced by long-term reduction in cerebral perfusion, which is associated with neurological deficits and high risk of stroke occurrence or recurrence. CCCI accounts for a large proportion of both outpatients and inpatients with cerebrovascular diseases, while management of CCCI remains a formidable challenge to clinicians. Normobaric oxygen (NBO) is an adjuvant hyperoxygenation intervention supplied with one atmosphere pressure (1 ATA =101.325 kPa). A plethora of studies have demonstrated the efficacy of NBO on the penumbra in acute stroke. NBO has been shown to increase the oxygen pressure, raise the intracranial blood flow, protect blood–brain barrier and enhance neuroprotective effects. As similar underlying mechanisms are shared by the penumbra in stroke and the ischemic–hypoxic brain tissues in CCCI, we speculate that NBO may serve as a promising therapeutic strategy for attenuating short-term symptoms or improving long-term clinical outcomes among patients with CCCI. Due to the scant research exploring the efficacy and safety of NBO for treating CCCI so far, both experimental and clinical studies are warranted to verify our hypothesis in the future. Keywords: chronic cerebral circulation insufficiency, normobaric oxygen, therapeutic strategy, stroke, clinical outcome
format article
author Ding J
Zhou D
Liu C
Pan L
Ya J
Ding Y
Ji X
Meng R
author_facet Ding J
Zhou D
Liu C
Pan L
Ya J
Ding Y
Ji X
Meng R
author_sort Ding J
title Normobaric oxygen: a novel approach for treating chronic cerebral circulation insufficiency
title_short Normobaric oxygen: a novel approach for treating chronic cerebral circulation insufficiency
title_full Normobaric oxygen: a novel approach for treating chronic cerebral circulation insufficiency
title_fullStr Normobaric oxygen: a novel approach for treating chronic cerebral circulation insufficiency
title_full_unstemmed Normobaric oxygen: a novel approach for treating chronic cerebral circulation insufficiency
title_sort normobaric oxygen: a novel approach for treating chronic cerebral circulation insufficiency
publisher Dove Medical Press
publishDate 2019
url https://doaj.org/article/820678d9e6cc4b378a4c9d2df73c5342
work_keys_str_mv AT dingj normobaricoxygenanovelapproachfortreatingchroniccerebralcirculationinsufficiency
AT zhoud normobaricoxygenanovelapproachfortreatingchroniccerebralcirculationinsufficiency
AT liuc normobaricoxygenanovelapproachfortreatingchroniccerebralcirculationinsufficiency
AT panl normobaricoxygenanovelapproachfortreatingchroniccerebralcirculationinsufficiency
AT yaj normobaricoxygenanovelapproachfortreatingchroniccerebralcirculationinsufficiency
AT dingy normobaricoxygenanovelapproachfortreatingchroniccerebralcirculationinsufficiency
AT jix normobaricoxygenanovelapproachfortreatingchroniccerebralcirculationinsufficiency
AT mengr normobaricoxygenanovelapproachfortreatingchroniccerebralcirculationinsufficiency
_version_ 1718401197719683072